LifeVantage(LFVN) - 2026 Q2 - Quarterly Results

Revenue Performance - Revenue for the second quarter of fiscal 2026 was $48.9 million, a decrease of 27.8% compared to the same period in fiscal 2025[5] - Revenue in the Americas region decreased by 32.6%, while revenue in the Asia/Pacific & Europe region decreased by 2.1%[5] - Total revenue for the three months ended December 31, 2025, was $48,931, a decrease of 28% compared to $67,762 in the same period of 2024[28] - For the six months ended December 31, 2025, revenue totaled $96,493,000, down from $114,976,000 in 2024[39] Profitability - Gross profit for the second quarter was $36.2 million, representing 74.0% of revenue, down from 80.5% in the prior year[6] - Net income for the second quarter was $0.3 million, or $0.02 per diluted share, compared to $2.6 million, or $0.19 per diluted share a year ago[10] - Adjusted EBITDA for the second quarter was $3.9 million, down from $6.5 million in the same period last year[11] - Gross profit for the six months ended December 31, 2025, was $74,026, down 20% from $92,290 in 2024[28] - Net income for the three months ended December 31, 2025, was $276, significantly lower than $2,550 in the same period of 2024[28] - Non-GAAP Adjusted EBITDA for the three months ended December 31, 2025, was $3,880, down from $6,474 in 2024[35] - GAAP Gross profit for the three months ended December 31, 2025, was $36,209,000, compared to $54,567,000 in 2024, reflecting a gross profit percentage of 74.0%[39] - Non-GAAP Gross profit for the three months ended December 31, 2025, was $38,577,000, with a gross profit percentage of 78.8%[39] - GAAP Gross profit for the six months ended December 31, 2025, was $74,026,000, compared to $92,290,000 in 2024, with a gross profit percentage of 76.7%[39] - Non-GAAP Gross profit for the six months ended December 31, 2025, was $76,394,000, maintaining a gross profit percentage of 79.2%[39] - The gross profit percentage decreased from 80.5% in Q4 2024 to 74.0% in Q4 2025, indicating a shift in profitability[39] - The company continues to focus on improving its gross profit margins despite the decline in revenue[39] Cash Flow and Financial Position - The company generated $0.5 million of cash from operations during the first six months of fiscal 2026, compared to $8.6 million in the same period of fiscal 2025[12] - Total liabilities decreased to $28,182 as of December 31, 2025, from $37,317 as of June 30, 2025[26] - Cash and cash equivalents decreased to $10,181 as of December 31, 2025, from $20,201 as of June 30, 2025[26] - Total stockholders' equity was $32,987 as of December 31, 2025, down from $34,641 as of June 30, 2025[26] Shareholder Actions - The company announced a new $60 million share repurchase program, replacing the previous program entirely[13] - A cash dividend of $0.045 per common share was declared, payable on March 16, 2026[14] Customer and Consultant Metrics - Active Independent Consultants decreased by 9.6% year-over-year to 47,000 as of December 31, 2025, from 52,000 in 2024[32] - Active Customers dropped by 27.7% to 68,000 in December 2025, compared to 94,000 in December 2024[32] Future Outlook - Fiscal 2026 revenue guidance is projected to be between $185 million and $200 million, with adjusted EBITDA expected to be between $15 million and $19 million[15] - The company plans to launch several new products in the LoveBiome line and expand into new international markets[4]